Vigil Neuroscience, Inc., (VIGL) Social Stream
Vigil Neuroscience Inc (VIGL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Vigil Neuroscience Inc.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-29 | 4 | $24 | $17 | $21 | $7.17 | 192.89% |
NA | 4 | $NA | $NA | $NA | $7.17 | NA% |
Over the past 56 days, VIGL's average upside potential has been 147.02%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-02-01 | 4 | 24 | 17 | 21 | 13.45 | 56.13% |
2022-03-25 | 4 | 24 | 17 | 21 | 7.38 | 184.55% |
2022-03-26 | 4 | 24 | 17 | 21 | 7.38 | 184.55% |
2022-03-29 | 4 | 24 | 17 | 21 | 7.99 | 162.83% |
VIGL Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Vigil Neuroscience Inc's number of analysts covering the stock is higher than 38.16% of them.
- Vigil Neuroscience Inc's average analyst price target is greater than 77.51% of stocks in the micro market cap category.
- In terms of how Vigil Neuroscience Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 73.38% of that group.
- In the context of Healthcare stocks, Vigil Neuroscience Inc's upside potential (average analyst target price relative to current price) is greater than 61.94% of them.
Stocks similar to Vigil Neuroscience Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TCRX, TCON, and TARA.
Is VIGL a Buy, Hold or Sell? See the POWR Ratings now!